Success Metrics

Clinical Success Rate
97.0%

Based on 32 completed trials

Completion Rate
97%(32/33)
Active Trials
1(3%)
Results Posted
19%(6 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_1
32
89%
Ph phase_4
1
3%
Ph not_applicable
2
6%
Ph phase_3
1
3%

Phase Distribution

32

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution36 total trials
Phase 1Safety & dosage
32(88.9%)
Phase 3Large-scale testing
1(2.8%)
Phase 4Post-market surveillance
1(2.8%)
N/ANon-phased studies
2(5.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

32 of 34 finished

Non-Completion Rate

5.9%

2 ended early

Currently Active

1

trials recruiting

Total Trials

36

all time

Status Distribution
Active(1)
Completed(32)
Terminated(2)
Other(1)

Detailed Status

Completed32
Withdrawn1
Terminated1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
1
Success Rate
97.0%
Most Advanced
Phase 4

Trials by Phase

Phase 132 (88.9%)
Phase 31 (2.8%)
Phase 41 (2.8%)
N/A2 (5.6%)

Trials by Status

withdrawn13%
completed3289%
terminated13%
unknown13%
recruiting13%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT07229404Phase 1

A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants

Completed
NCT07214922Phase 1

Relative Bioavailability of Evobrutinib Tablet Batches

Completed
NCT06453265Phase 1

A Study to Assess the Abuse Potential of Intranasal Cebranopadol

Completed
NCT07162441Phase 1

A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

Recruiting
NCT06661694Phase 1

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Withdrawn
NCT05578846Phase 1

Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics

Completed
NCT05122143Not Applicable

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Completed
NCT04600505Phase 1

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Completed
NCT05195892Phase 1

Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers

Completed
NCT05463497Phase 1

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

Completed
NCT04049175Phase 3

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

Terminated
NCT04798222Phase 1

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Completed
NCT04970940Phase 1

The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

Completed
NCT03804645Phase 1

A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Completed
NCT00902512Phase 4

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Completed
NCT03942666Phase 1

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

Completed
NCT03441984Phase 1

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

Completed
NCT04087187Phase 1

A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

Completed
NCT03978143Phase 1

Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants

Completed
NCT01490788Phase 1

A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
36